Alembic Pharmaceuticals Debt & Borrowing
Alembic Pharmaceuticals submitted a certificate confirming the utilization of proceeds from Commercial Papers for the quarter ended September 30, 2026, as required by SEBI regulations.
ALFA Filings
Every announcement, straight from the exchange
Every Alembic Pharmaceuticals debt & borrowing announcement on NSE and BSE, newest first, each with its own page.
Time
5 announcements with these filters
Alembic Pharmaceuticals submitted a certificate confirming the utilization of proceeds from Commercial Papers for the quarter ended September 30, 2026, as required by SEBI regulations.
Alembic Pharmaceuticals has redeemed commercial papers worth ₹200 Crore on their maturity date, 28th September 2026. This confirms the company's full repayment of the debt obligation.
Alembic Pharmaceuticals Limited has redeemed Commercial Papers (CP) worth Rs. 100 Crores. The redemption was completed on the maturity date of September 25, 2026.
Alembic Pharmaceuticals has redeemed Commercial Papers worth Rs. 150 Crore upon maturity on 23rd September 2026.
Alembic Pharmaceuticals has successfully redeemed Commercial Papers worth ₹150 Crore upon maturity. This confirms the repayment of the company's debt obligation.